News • Heart perfusion simulator
iHEART: a new model to boost cardiac research
A team at Politecnico di Milano developed iHEART, a mathematical and computational model of the human heart designed for studying coronary artery disease.
A team at Politecnico di Milano developed iHEART, a mathematical and computational model of the human heart designed for studying coronary artery disease.
Engineers from MIT are developing a device containing insulin-producing cells and a tiny oxygen-producing factory to keep the cells of diabetes patients healthy.
Researchers from the University of Tsukuba have improved the imaging resolution of the magnetic resonance microscope, to obtain high-resolution images of embryos.
A genetic test for BRCA1 or BRCA2 gene mutations may drive women to undergo breast cancer surgery, even though their risk might not even be drastically affected by this, a new study finds.
A newly discovered mechanism involving exosomes can drive inflammation and impair healing of wounds in diabetes patients, according to a new study led by University of Pittsburgh and UPMC researchers.
Chemotherapy can be an effective means to fight breast cancer, but under certain circumstances, the treatment can cause dormant cancer cells to re-awaken, new research finds.
Basque researchers propose a bioelectronic device consisting of gold electrodes coated with a smart polymer capable of capturing and releasing cells in a non-invasive, controllable way.
A new research breakthrough could lead to the development of new treatments for people with compromised immune systems, such as those with cystic fibrosis.
Half as thick as a human hair: Researchers at TU Munich have developed the world's first microrobot capable of navigating within groups of cells and stimulating individual cells.
A new nanocomplex renders a tumor harmless – and, on top of that, it trains the immune system to detect and eliminate metastases.
Brexit has also been a disconnect for many joint research projects. The news of the UK rejoining the "Horizon Europe" programme feels like a silver lining for many.
A new type of microdevice could offer new ways to treat brain cancer. The shape and size of a grain of rice, it is implanted into a tumor to study the effects of ongoing therapies.
It had long been recognized that the brain was made up of two types of cells, neurons and glial cells. Now, neuroscientists discovered an additional type - with huge implications for brain disorders.
Cancer has become strikingly more common in people under 50 in the past three decades, an international research team finds. The reseachers explore what this means for future death tolls.
Where are the beginnings of breast cancer? A team of researchers at Kyoto University has revealed the mechanism by which breast cancer is formed in the cells of mammalian epithelium.
Spinal fusion is a highly invasive surgery where an implant is placed in the spine to prevent movement between bones. Currently, failure rate is high, but a new prototype device could change this.
Heatwaves, wildfires, flooding: effects of climate change will further exacerbate breathing difficulties for millions of people living with lung conditions, new research finds.
For the first time, researchers show that AI-based predictions can deliver comparable results to clinical tests on biopsies of patients with colorectal cancer (CRC).
Can per- and polyfluoroalkyl substances (PFAS) increase the risk of breast cancer? A new study by US researchers examines the effects of the so-called “forever chemicals”.
New research finds the use of an electric field a promising means to prevent aerosol spread of viruses in healthcare environments, for example during surgery.
Using data from more than 400,000 individuals, researchers have created a platform for predicting the risk of developing blood cancers such as acute myeloid leukaemia over a 10-15-year period.
A new approach to treating kidney failure could one day free people from needing dialysis or having to take harsh drugs to suppress their immune system after a transplant.
Cardiovascular disease (CVD) cost the EU an estimated €282 billion in 2021, according to late breaking research presented at the European Society of Cardiology's ESC Congress 2023.
Patients with immunodeficiency cannot benefit from conventional Covid-19 vaccines and still at risk from infection. A promising new approach now brings hope for this patient group.
Using a defibrillator for a cardiac arrest victim improves 30-day survival even with ambulance response times as short as two minutes, according to research presented at ESC Congress 2023.